Efficacy and tolerability of blonanserin versus aripiprazole in Japanese patients with psychotic disorder: a randomized, masked-rater trial

Trial Profile

Efficacy and tolerability of blonanserin versus aripiprazole in Japanese patients with psychotic disorder: a randomized, masked-rater trial

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Blonanserin (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jan 2017 Status changed from recruiting to completed.
    • 31 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top